Fennec Pharma (NASDAQ: FENC) CFO sells 75K shares in plan trade
Rhea-AI Filing Summary
FENNEC PHARMACEUTICALS INC. (FENC) reported insider activity by Chief Financial Officer Robert Andrade. On August 28, 2026, he exercised 21,928 stock options at an exercise price of $5.10 per share, acquiring the same number of common shares, and held 779,330 stock options directly after this exercise. On August 27, 2026, he sold 75,000 common shares at $11.78 per share pursuant to a Rule 10b5-1 trading plan adopted on May 22, 2026, with a portion of the proceeds used to pay his tax obligations.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary 10b5-1
Exercise and sale activity reported; no spread calculated
Exercise and Sale
3 txns
Insider
Andrade Robert
Role
CHIEF FINANCIAL OFFICER
Sold
75,000 shs ($884K)
Approx. gross sale proceeds
$884K
Approx. exercise cost
$112K
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options F2 | 21,928 | $0.00 | $0.00 |
| Exercise | Common shares F2 | 21,928 | $5.10 | $112K |
| Sale | Common shares F1 | 75,000 | $11.78 | $884K |
Holdings After Transaction:
Stock Options — 779,330 shares (Direct);
Common shares — 239,603 shares (Direct)
Footnotes (2)
- F1. Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2026, which is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). A portion of the sales proceeds from this transaction will be used by the reporting person to pay tax obligations of the reporting person.
- F2. Shares acquired through the exercise of an option contract with exercise price of $5.10 and an expiration date of June 27, 2027.
Key Figures
Shares sold: 75,000 common shares
Sale price: $11.78 per share
Options exercised: 21,928 stock options
+3 more
6 metrics
Shares sold
75,000 common shares
Sale on 2026-08-27 by CFO Robert Andrade at $11.78 per share
Sale price
$11.78 per share
Price for 75,000 common shares sold on 2026-08-27
Options exercised
21,928 stock options
Exercised on 2026-08-28 into 21,928 common shares
Exercise price
$5.10 per share
Exercise price of options exercised on 2026-08-28; option expiration June 27, 2027
Stock options held after transaction
779,330 stock options
Directly held by Robert Andrade following the reported exercise
Rule 10b5-1 plan adoption date
May 22, 2026
Trading plan under which the 75,000-share sale was executed
Key Terms
Rule 10b5-1 trading plan, exercise price, expiration date
3 terms
Rule 10b5-1 trading plan regulatory
"Represents shares sold pursuant to a Rule 10b5-1 trading plan adopted"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
exercise price financial
"Shares acquired through the exercise of an option contract with exercise price"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"option contract with exercise price of $5.10 and an expiration date of June 27, 2027"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transactions did FENC CFO Robert Andrade report in this Form 4?
He reported exercising 21,928 stock options at $5.10 per share on August 28, 2026 to acquire the same number of common shares, and selling 75,000 common shares at $11.78 per share on August 27, 2026.
How many FENC stock options does Robert Andrade hold after these transactions?
After the reported option exercise, Robert Andrade directly holds 779,330 stock options of FENNEC PHARMACEUTICALS INC., as stated in the Form 4 data.
What are the key terms of the exercised FENC options reported by the CFO?
The exercised options relate to an option contract with an exercise price of $5.10 per share and an expiration date of June 27, 2027, covering 21,928 shares of Fennec common shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
